Reading Room
Find articles about healthcare-associated infection published in The Lancet journals

Conference Programme: Agenda

Lancet conference on managing healthcare-associated infections

Day 1
08:30-08.45	Welcome and background
	Overview
08:45-09:10	History and changing epidemiology of HAIs Andrew Pearson Consultant epidemiologist, Department of Healthcare-Associated Infection and Antimicrobial Resistance, Communicable Disease Surveillance Centre, HPA Centre for Infections, London, UK
09:10-09:35	International comparison of HAI epidemiology Hajo Grundmann Professor of epidemiology, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
09:35-10:00	International comparison of the social, media, and political context of HAIs Tammy Boyce Senior research fellow, The King's Fund, London, UK.
10:00-10:25	Break
	Specific pathogens and problems I
10:25-10:50	Glycopeptide-resistant enterococci Marc Bonten Professor of molecular epidemiology of infectious diseases, Department of Medical Microbiology, Julius Centre for Health Sciences & Primary Care, University Medical Centre, Utrecht, Netherlands.
10:50-11:15	Pseudomonas Kevin Kerr Consultant microbiologist and Director of Infection Prevention and Control, Harrogate and District NHS Foundation Trust, Harrogate, UK.
11:15-11:40	ESBL-producing organisms Matthew Falagas Director of the Alfa Institute of Biomedical Sciences, Athens, Greece, and Director of the Infectious Diseases Clinic, Henry Dunant Hospital, Athens.
11:40-12:05	Norovirus Marion Koopmans Professor in public-health virology, Erasmus Medical Centre, and Head of virology, Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Netherlands
12:05-12:30	Q&A
12:30-14:00	Lunch
	Specific pathogens and problems II
14:00-14:25	Surgical-site infections Hilary Humphreys Professor of clinical microbiology and Head of the Department Microbiology, Royal College of Surgeons of Ireland, Dublin, Ireland.
14:25-14:50	Prevention of ventilator-associated pneumonia Jean Yves Fagon Head of the Department of Réanimation Médicale, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Université Paris-Descartes, Paris, France
14:50-15:15	Catheter-related infections Jonathan Edgeworth Consultant microbiologist, Guy's and St Thomas' NHS Foundation Trust, London, UK
15:15-15:40	Q&A
1540-1600	Break
	Prevention and control
16:00-16:25	The role of hand hygiene Benedetta Allegranzi World Alliance for Patient Safety, World Health Organization, Geneva, Switzerland.
16:25-16:50	Environmental decontamination and HAIs Stephanie Dancer Department of Microbiology, Hairmyres Hospital, East Kilbride, UK
16:50-17:15	The role of screening and isolation Evelina Tacconelli Department of Infectious Diseases, Università Cattolica Sacro Cuore, Rome , Italy
17:15-17:40	Rapid diagnosis of HAIs Peter Hawkey Consultant medical microbiologist, West Midlands Public Health Laboratory, Birmingham Heart of England NHS Trust, Birmingham, UK.

Day 2
08:30-09:00	Responsibility for managing HAIs: where does the buck stop? Brian Duerden Inspector of microbiology and infection control, Department of Health, London, UK
09:00-09:10	Q&A
	Specific pathogens and problems III
09:10-09:35	Hospital-acquired MRSA Gary French Professor of microbiology, King's College, London, UK, and Consultant in microbiology and Clinical Lead in infection control, Guy's and St Thomas' NHS Foundation Trust, London.
09:35-10:00	Community-associated MRSA as a cause of HAIs Robert Skov National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark
10:00-10:20	Q&A
10:20-10:50	Break
10:50-11:15	Clostridium difficile Mark Wilcox Professor of medical microbiology, University of Leeds, Leeds, UK, and Head of microbiology and Clinical Director of pathology and infection control doctor for the Leeds teaching hospitals.
11:15-11:40	Acinetobacter Kevin Towner Consultant clinical scientist, Department of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
11:40-12:00	Q&A
12:00-13:30	Lunch
	Controversies I
13:30-13:55	What is more important in the control of HAI-infection control or antibiotic manipulation? Ian Gould Consultant microbiologist, Aberdeen Royal Infirmary, Aberdeen, UK
13:55-14:20	What is the link between antibiotic use and antibiotic resistance? Herman Goossens Professor of medical microbiology, University of Antwerp, Antwerp, Belgium.
14:20-14:45	HAI control: what efforts are needed and what are the benefits? Christina Vandenbroucke-Grauls Department of Medical Microbiology and Infection Control, VU University Medical Center , Amsterdam , The Netherlands
14:45-15:15	Q&A
15:15-15:45	Break
	Controversies II
15:45-16:10	Where does infection control fit into a hospital management structure? Alison Holmes Reader in hospital epidemiology and infection control, Division of Investigative Science, Imperial College, London, UK
16:10-16:35	Are targets the right way to improve infection control practice? Michael Millar Medical microbiologist, Barts and the London NHS Trust, London, UK.
16:35-17:00	Do the public have a right to know the HAI rate in your hospital? Martin Fletcher Chief Executive, National Patient Safety Agency in England, London, UK.
17:00-17:25	Q&A
17:25-17:45	Concluding remarks Didier Pittet Director of the infection control programme, University of Geneva Hospitals and Clinics, Geneva, Switzerland, and Professor of Medicine and Hospital Epidemiology, University of Geneva.
17:45	Closing